ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Appili Therapeutics Inc

Appili Therapeutics Inc (APLI)

0.035
0.00
(0.00%)
終了 2月11日 6:12AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.035
買値
0.03
売値
0.035
出来高
1
0.00 日の範囲 0.00
0.025 52 週間の範囲 0.06
時価総額
前日終値
0.035
始値
-
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
60,044
発行済株式数
121,266,000
配当利回り
-
PER
-0.96
1 株当たり利益 (EPS)
-0.03
歳入
6.69M
純利益
-3.78M

Appili Therapeutics Inc について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Halifax, Nova Scotia, Can
設立
-
Appili Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the トロント証券取引所 with ticker APLI. The last closing price for Appili Therapeutics was $0.04. Over the last year, Appili Therapeutics shares have traded in a share price range of $ 0.025 to $ 0.06.

Appili Therapeutics currently has 121,266,000 shares in issue. The market capitalisation of Appili Therapeutics is $4.24 million. Appili Therapeutics has a price to earnings ratio (PE ratio) of -0.96.

APLI 最新ニュース

Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials

Submission for Regulatory Approval to Initiate Human Trials for Type 1 Diabetes, Psoriasis, and Stiff-Person Syndrome Targeted for H2 2025 Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”...

Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Court’s approval allows transaction with Aditxt to proceed, subject to other closing conditions...

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025

Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in...

Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares

Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024 Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social...

Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target...

Appili Therapeutics Announces Results of Special Meeting of Shareholders

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI;...

Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, announced today that its acquisition target, Evofem...

Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target...

Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for...

Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.0350.0350.03247000.0342996CS
4000.0350.040.03427610.03472236CS
120.00516.66666666670.030.0450.03600440.03400064CS
26000.0350.0450.025797470.03350526CS
520.01400.0250.060.0251208900.03770564CS
156-0.085-70.83333333330.120.170.0251489210.05496758CS
260-1.095-96.90265486731.131.60.0251601930.27209111CS

APLI - Frequently Asked Questions (FAQ)

What is the current Appili Therapeutics share price?
The current share price of Appili Therapeutics is $ 0.035
How many Appili Therapeutics shares are in issue?
Appili Therapeutics has 121,266,000 shares in issue
What is the market cap of Appili Therapeutics?
The market capitalisation of Appili Therapeutics is CAD 4.24M
What is the 1 year trading range for Appili Therapeutics share price?
Appili Therapeutics has traded in the range of $ 0.025 to $ 0.06 during the past year
What is the PE ratio of Appili Therapeutics?
The price to earnings ratio of Appili Therapeutics is -0.96
What is the cash to sales ratio of Appili Therapeutics?
The cash to sales ratio of Appili Therapeutics is 0.54
What is the reporting currency for Appili Therapeutics?
Appili Therapeutics reports financial results in CAD
What is the latest annual turnover for Appili Therapeutics?
The latest annual turnover of Appili Therapeutics is CAD 6.69M
What is the latest annual profit for Appili Therapeutics?
The latest annual profit of Appili Therapeutics is CAD -3.78M
What is the registered address of Appili Therapeutics?
The registered address for Appili Therapeutics is 21-1344 SUMMER STREET, HALIFAX, NOVA SCOTIA, B3H 0A8
What is the Appili Therapeutics website address?
The website address for Appili Therapeutics is www.appilitherapeutics.com
Which industry sector does Appili Therapeutics operate in?
Appili Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NCFNorthcliff Resources Ltd
$ 0.05
(42.86%)
1.68M
ELEFSilver Elephant Mining Corp
$ 0.255
(37.84%)
29.13k
VRTSVertiqal Studios Corporation
$ 0.02
(33.33%)
685k
CNTCentury Global Commodities Corporation
$ 0.03
(20.00%)
90k
FLNTFlint Corporation
$ 0.03
(20.00%)
50k
MPVDMountain Province Diamonds Inc
$ 0.06
(-20.00%)
758.77k
WLLWWillow Biosciences Inc
$ 0.025
(-16.67%)
271.67k
RTGRTG Mining Inc
$ 0.025
(-16.67%)
3.16k
TTNMTitanium Transportation Group Inc
$ 1.78
(-14.83%)
240.26k
NPKVerde Agritech Ltd
$ 0.75
(-12.79%)
86.75k
SUSuncor Energy Inc
$ 56.56
(2.20%)
15.98M
TDToronto Dominion Bank
$ 86.01
(3.86%)
14.78M
MFCManulife Financial Corporation
$ 42.73
(-0.77%)
14.57M
ENBEnbridge Inc
$ 64.12
(0.96%)
12.3M
BTEBaytex Energy Corp
$ 3.67
(5.46%)
6.85M

APLI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock